• The Accord grants Kenya access to over 140 vital medications on a not-for-profit basis, significantly boosting supplies in public hospitals.

Kenya has taken a step towards improving healthcare accessibility with the launch of a groundbreaking accord between the Ministry of Health and Pfizer, an American multinational pharmaceutical and biotechnology corporation.

This initiative, unveiled by Principal Secretary for Medical Services Dr. Ouma Oluga and Pfizer Global President for Emerging Markets Nick Lagunowich on June 24, 2025, promises to save the country up to 60% on essential medicines for diabetes, cancer, and infectious diseases.

The Accord grants Kenya access to over 140 vital medications on a not-for-profit basis, significantly boosting supplies in public hospitals.

 “We’re reducing the cost burden on our patients to make lifesaving care affordable,” stated Dr. Oluga.

To further support this initiative, the Ministry of Health plans to invest in retraining health workers through competence-based in-service training. This effort aims to minimize clinical negligence and improve patient outcomes across all healthcare levels.

Read More

  1. Murkomen: Kenya's Police Service Is Africa's Most Professional Amid Turmoil
  2. The Art of Becoming: A Raw Love Letter to Growing Up
  3. Creativity: The Power of Self-Reflection in Writing

In addition to the Accord, reforms such as the establishment of the Social Health Authority and a new law on quality care—currently under public participation, will serve as the foundation for these transformative changes. “This is how we build a self-reliant system,” Dr. Oluga remarked.

Lagunowich echoed this sentiment, highlighting Pfizer's dedication to equitable access to healthcare. “Access to quality medicines shouldn’t depend on geography or income. Through this Accord, we’re proud to support Kenya’s bold journey toward Universal Health Coverage.”